Evaluation of serum semaphorin-3A and interleukin 6 levels in patients with neovascular age-related macular degeneration
| dc.contributor.author | Okutucu, Murat | |
| dc.contributor.author | Arpa, Medeni | |
| dc.date.accessioned | 2026-11-17T06:25:19Z | |
| dc.date.issued | 2026 | |
| dc.department | RTEÜ, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü | |
| dc.department | RTEÜ, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü | |
| dc.description.abstract | Purpose: To determine whether serum semaphorin 3 A (Sema3A) and interleukin 6 (IL-6) play a role in the common etiopathogenesis of nAMD and nAMD-associated systemic diseases by evaluating these mediators levels. Methods: This prospective case–control study included 74 patients divided into nAMD (n = 33) and a control group (n = 41). Serum Sema3A and IL-6 levels were analyzed using the enzyme-linked immunosorbent assay. Results: The nAMD group had a statistically higher IL-6 level [5,9 (1–16,9) pg/mL], compared to the control group [1,5 (0,38 − 2,96) pg/mL] (p < 0.001). On the other hand, the Sema3A level of the nAMD group was lower at [26,3 (11,5-100) ng/mL] compared to the control group at [44,7 (16,8-100) ng/mL] (p < 0.001). The IL-6 level in the hypertension (+) group [2,5 (0,5–16,9) pg/ml] was significantly higher than that in the hypertension (-) group [1,7 (0,4–15,3) pg/ml] (p < 0.001). No significant difference was found between the hypertension (+) and hypertension (−) groups in terms of SEMA3A level. There was a negative correlation between serum SEMA3A and serum IL-6 levels of the whole participants (p < 0.001, r=-0.471). Conclusions: Decreased levels of the anti-inflammatory and anti-angiogenic mediator Sema3A and increased levels of inflammatory mediator IL-6 detected in nAMD suggest that these molecules may play a role in systemic manifestations of this syndrome, such as inflammation, cardiovascular diseases, atrial fibrillation, and Alzheimer’s disease. | |
| dc.identifier.citation | Okutucu, M., & Arpa, M. (2026). Evaluation of serum semaphorin-3A and interleukin 6 levels in patients with neovascular age-related macular degeneration. BMC ophthalmology, 26(1), 634. https://doi.org/10.1186/s12886-026-05128-6 | |
| dc.identifier.doi | 10.1186/s12886-026-05128-6 | |
| dc.identifier.issn | 1471-2415 | |
| dc.identifier.issue | 1 | |
| dc.identifier.scopus | 2-s2.0-105052989814 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.startpage | 634 | |
| dc.identifier.uri | https://doi.org/10.1186/s12886-026-05128-6 | |
| dc.identifier.uri | https://hdl.handle.net/11436/13796 | |
| dc.identifier.volume | 26 | |
| dc.indekslendigikaynak | Scopus | |
| dc.institutionauthor | Okutucu, Murat | |
| dc.institutionauthor | Arpa, Medeni | |
| dc.institutionauthorid | 0000-0001-8321-4829 | |
| dc.language.iso | en | |
| dc.publisher | BioMed Central Ltd | |
| dc.relation.ispartof | BMC Ophthalmology | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Alzheimer’s disease | |
| dc.subject | Atrial fibrillation | |
| dc.subject | Cardiovascular disease | |
| dc.subject | Inflammation | |
| dc.subject | Interleukin 6 | |
| dc.subject | Neovascular age related macular degeneration | |
| dc.subject | Semaphorin-3A | |
| dc.title | Evaluation of serum semaphorin-3A and interleukin 6 levels in patients with neovascular age-related macular degeneration | |
| dc.type | Article |











